430 related articles for article (PubMed ID: 26946925)
21. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial.
Darouiche RO; Berger DH; Khardori N; Robertson CS; Wall MJ; Metzler MH; Shah S; Mansouri MD; Cerra-Stewart C; Versalovic J; Reardon MJ; Raad II
Ann Surg; 2005 Aug; 242(2):193-200. PubMed ID: 16041209
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.
van de Wetering MD; van Woensel JB; Lawrie TA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD003295. PubMed ID: 24277633
[TBL] [Abstract][Full Text] [Related]
23. Use of impregnated catheters to decrease colonization rates in neonates - A randomized controlled pilot trial.
Klemme M; Staffler A; De Maio N; Lauseker M; Schubert S; Innocenti P; Wurster TM; Foerster K; Herber-Jonat S; Mittal R; Messner H; Flemmer AW
J Neonatal Perinatal Med; 2020; 13(2):231-237. PubMed ID: 31609709
[TBL] [Abstract][Full Text] [Related]
24. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates.
Friedman BC; Mian MA; Mullins RF; Hassan Z; Shaver JR; Johnston KK
J Burn Care Res; 2015; 36(4):493-9. PubMed ID: 25407386
[TBL] [Abstract][Full Text] [Related]
25. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
Pearse I; Marsh N; Rickard CM; Ullman AJ; Larsen E; Pelecanos A; McGuinness N; Irvine L; Rapchuk IL; Ziegenfuss M; Corley A
Aust Crit Care; 2022 Sep; 35(5):512-519. PubMed ID: 34321181
[TBL] [Abstract][Full Text] [Related]
26. Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial.
Rickard CM; Marsh NM; Larsen EN; McGrail MR; Graves N; Runnegar N; Webster J; Corley A; McMillan D; Gowardman JR; Long DA; Fraser JF; Gill FJ; Young J; Murgo M; Alexandrou E; Choudhury MA; Chan RJ; Gavin NC; Daud A; Palermo A; Regli A; Playford EG
Lancet; 2021 Apr; 397(10283):1447-1458. PubMed ID: 33865494
[TBL] [Abstract][Full Text] [Related]
27. Generalisability and Cost-Impact of Antibiotic-Impregnated Central Venous Catheters for Reducing Risk of Bloodstream Infection in Paediatric Intensive Care Units in England.
Harron K; Mok Q; Hughes D; Muller-Pebody B; Parslow R; Ramnarayan P; Gilbert R
PLoS One; 2016; 11(3):e0151348. PubMed ID: 26999045
[TBL] [Abstract][Full Text] [Related]
28. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
[TBL] [Abstract][Full Text] [Related]
29. Comparison of chlorhexidine impregnated dressing and standard dressing for the prevention of central-line associated blood stream infection and colonization in critically ill pediatric patients: A randomized controlled trial.
Duyu M; Karakaya Z; Yazici P; Yavuz S; Yersel NM; Tascilar MO; Firat N; Bozkurt O; Caglar Mocan Y
Pediatr Int; 2022 Jan; 64(1):e15011. PubMed ID: 34610185
[TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis.
Sheng KX; Zhang P; Li JW; Cheng J; He YC; Böhlke M; Chen JH
Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208
[TBL] [Abstract][Full Text] [Related]
31. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
Maki DG; Stolz SM; Wheeler S; Mermel LA
Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
[TBL] [Abstract][Full Text] [Related]
32. Central venous catheter-associated bloodstream infections in a pediatric intensive care unit: effect of the location of catheter insertion.
Krishnaiah A; Soothill J; Wade A; Mok QQ; Ramnarayan P
Pediatr Crit Care Med; 2012 May; 13(3):e176-80. PubMed ID: 22561276
[TBL] [Abstract][Full Text] [Related]
33. Effect of impregnated central venous catheters on thrombosis in paediatric intensive care: Post-hoc analyses of the CATCH trial.
Wu Y; Fraser C; Gilbert R; Mok Q
PLoS One; 2019; 14(3):e0214607. PubMed ID: 30921401
[TBL] [Abstract][Full Text] [Related]
34. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation.
Mallucci CL; Jenkinson MD; Conroy EJ; Hartley JC; Brown M; Dalton J; Kearns T; Moitt T; Griffiths MJ; Culeddu G; Solomon T; Hughes D; Gamble C;
Lancet; 2019 Oct; 394(10208):1530-1539. PubMed ID: 31522843
[TBL] [Abstract][Full Text] [Related]
36. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
[TBL] [Abstract][Full Text] [Related]
37. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial).
Pickard R; Lam T; Maclennan G; Starr K; Kilonzo M; McPherson G; Gillies K; McDonald A; Walton K; Buckley B; Glazener C; Boachie C; Burr J; Norrie J; Vale L; Grant A; N'dow J
Health Technol Assess; 2012 Nov; 16(47):1-197. PubMed ID: 23199586
[TBL] [Abstract][Full Text] [Related]
38. Prevention of nosocomial bloodstream infections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters.
Marin MG; Lee JC; Skurnick JH
Crit Care Med; 2000 Sep; 28(9):3332-8. PubMed ID: 11008998
[TBL] [Abstract][Full Text] [Related]
39. Chlorhexidine-Impregnated Dressings and Prevention of Catheter-Associated Bloodstream Infections in a Pediatric Intensive Care Unit.
Düzkaya DS; Sahiner NC; Uysal G; Yakut T; Çitak A
Crit Care Nurse; 2016 Dec; 36(6):e1-e7. PubMed ID: 27908954
[TBL] [Abstract][Full Text] [Related]
40. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
